Journal
NATURE REVIEWS CANCER
Volume 1, Issue 1, Pages 68-76Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/35094077
Keywords
-
Categories
Ask authors/readers for more resources
One protein - p53 - plays nemesis to most cancers by condemning damaged cells to death or quarantining them for repair. But the activity of p53 relies on its intact native conformation, which can be lost following mutation of a single nucleotide. With thousands of such mutations identified in patients, how can a future cancer drug buttress this fragile protein structure and restore the cell's natural defence?.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available